Retail network access is facilitated through agreements with United Networks of America (UNA). Display of pharmacy brand marks does not imply ownership, endorsement, or direct partnership with XRP Healthcare M&A Holding Inc.
Technology partnerships reflect collaborative or project-based cooperation. Display does not imply equity ownership or endorsement unless expressly stated.
Pharmaceutical and supply relationships reflect existing commercial arrangements within acquired operating entities. Display does not imply exclusivity or endorsement beyond standard commercial supply agreements.
Advisors provide professional services to XRP Healthcare M&A Holding Inc. No partnership or ownership interest is implied unless publicly disclosed.
All third-party trademarks remain the property of their respective owners. Display does not imply endorsement, ownership, or partnership unless expressly stated.
Jul 3, 2025
XRP Healthcare is taking a major step toward the public markets-and doing so alongside one of the industry’s most recognized financial advisory firms. ARC Group, the same advisory firm involved in the public market
XRP Healthcare is taking a major step toward the public markets-and doing so alongside one of the industry’s most recognized financial advisory firms. ARC Group, the same advisory firm involved in the public market debut of Trump Media, is now guiding XRP Healthcare’s proposed IPO. ARC Group to Lead XRP Healthcare’s Strategic Move Into the Public Markets.
Known for helping high-growth and disruptive companies navigate the path to becoming publicly traded businesses, ARC Group brings significant credibility and experience to the process. Their involvement with XRP Healthcare signals more than just advisory support-it reflects strategic alignment, investor confidence, and strong market readiness.
Abraham Cinta, CEO of ARC Group, shared his perspective on the future potential of XRP Healthcare:
“Going public puts a spotlight on your business like nothing else. The exposure can accelerate growth by tenfold-maybe even more.”
“With the right structure and execution, we believe XRP Healthcare has the potential to evolve into a multi-billion-dollar company.”
Coming from a firm experienced in scaling and listing transformative businesses, these statements carry considerable weight. They reflect not only optimism, but also confidence built on industry expertise and market experience.
For XRP Healthcare, the IPO represents far more than a corporate milestone. It serves as a platform to accelerate growth, strengthen trust with global stakeholders, and unlock opportunities across emerging healthcare markets. A successful public listing would enhance credibility, attract broader institutional interest, and support technological and operational expansion at scale.
This moment represents an important evolution in the company’s journey. With ARC Group helping guide the process, XRP Healthcare is positioning itself to become a notable name within the healthtech IPO landscape.
Watch the full interview in the latest edition of XRP Healthcare Magazine:
https://issuu.com/xrphealthcare/docs/xrp_healthcare_magazine_issue_5/20